Association between proton pump inhibitors and periodontal disease severity
Abstract Objectives Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid‐related gastrointestinal disorders. PPIs modulate osteoclast function, reduce gastric acid secretion, and are associated with the establishment of a more diverse gastrointestinal microbiota. Periodon...
Zapisane w:
Główni autorzy: | Bhavneet K. Chawla (Autor), Robert E. Cohen (Autor), Lisa M. Yerke (Autor) |
---|---|
Format: | Książka |
Wydane: |
Wiley,
2022-02-01T00:00:00Z.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review
od: Bhavneet K. Chawla, i wsp.
Wydane: (2022) -
Proton-pump inhibitors and risk of renal disease
od: Mahrang Hedaiaty, i wsp.
Wydane: (2017) -
Is hypomagnesemia associated with using proton pump inhibitors?
od: Joo-Hark Yi, i wsp.
Wydane: (2016) -
Proton-pump inhibitor use amongst patients with severe hypomagnesemia
od: Sherry Seah, i wsp.
Wydane: (2023) -
RENAL SAFETY OF PROTON PUMP INHIBITORS
od: A. I. Dyadyk, i wsp.
Wydane: (2017)